Added to YB: 2026-04-01
Pitch date: 2026-03-25
PBH [bullish]
Prestige Consumer Healthcare Inc.
-2.63%
current return
Author Info
No bio for this author
Company Info
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Market Cap
$2.8B
Pitch Price
$60.87
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.67
P/E
15.62
EV/Sales
3.46
Sector
Pharmaceuticals
Category
value
Heartland Opportunistic Value Equity Strategy Portfolio Holding: Prestige Consumer Healthcare Inc.
PBH (new position): OTC brands (Dramamine, Clear Eyes, CompoundW) down 30%+ on eye care supply chain issues. Fixed via $100M supplier acquisition. Eye care recovery + customer restocking should drive 2027 EPS acceleration. Trades 13x fwd P/E, 6.5% FCF/EV yield vs historical premium valuation.
Read full article (1 min)